Dror Bashan | President, Chief Executive Officer |
Eyal Rubin | Senior Vice President, Chief Financial Officer |
Charles Padala | LifeSci Advisors |
John Vandermosten | Zacks Small Cap Research |
Good morning ladies and gentlemen and welcome to Protalix BioTherapeutics’ full year 2021 earnings conference call. At this time, all participants are in a listen-only mode and the conference is being recorded. I will now turn the conference over to our host, Mr. Chuck Padala of LifeSci Advisors, investor relations for Protalix. Thank you, please go ahead.